Beyond The Printed Page

  1. 2023 Manufacturing And Supply Chain Outlook: Additional Insights 12/16/2022

    Additional executive responses to our 2023 manufacturing and supply chain outlook questions.

  2. 2023 Finance And Funding Outlook: Additional Insights Part 2 12/9/2022

    Additional experts weigh in on Life Science Leader's 2023 finance and funding outlook questions.

  3. 2023 Finance And Funding Outlook: Additional Insights Part 1 12/2/2022

    Biopharma executives offer options, tips and strategies for navigating finance and funding challenges in 2023.

  4. Big Pharma CEOs Discuss Collaboration, Talent And IRA Implications At Galien Forum 11/9/2022

    This article is part two of a two-part series covering the highlights of the Galien Forum. Part 1 can be accessed here.

  5. Industry Leaders Talk Pricing, Accelerated Approval, Diversity At Galien Forum 11/4/2022

    Part one of a two-part series covering highlights from the Galien Forum in New York City, held on October 27.

  6. MAPS: Walking The Talk On Intellectual Property? 4/29/2022

    Did MAPS, a leader in the psychedelic medicines space, just make good on its promise to share its intellectual property, as opposed to wielding it against competitors?

  7. Where Patients Meet Policy: The EveryLife Foundation For Rare Diseases 4/1/2022

    The year before he founded Ultragenyx, Emil Kakkis created the EveryLife Foundation for Rare Diseases, a nonprofit patient advocacy organization focused on the “equitable development of and access to lifesaving diagnoses, treatments, and cures.” We caught up with Annie Kennedy, chief of policy and advocacy at the EveryLife Foundation, to learn more about the issues and policies the foundation is prioritizing this year.

  8. Ever Learn A Lesson The Hard Way? 1/24/2022

    Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, shares a lesson learned the hard way involving an exit from a previous startup.

  9. Starting A Company … In Another Country 1/17/2022

    Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, discusses challenges associated with building a biopharma startup in another country.

  10. A Lesson In Leadership From Lara Sullivan 12/22/2021

    Lara Sullivan, M.D., CEO of Pyxis Oncology, shares a story showing the impact had by employees in creating the right corporate culture.